Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
About this item
Full title
Author / Creator
Geng, Jinsong , Yu, Hao , Mao, Yiwei , Zhang, Peng and Chen, Yingyao
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of antidiabetic drugs used for treating type 2 diabetes mellitus. While many studies have reported on the cost-effectiveness of DPP-4 inhibitors for treating type 2 diabetes, a systematic review of economic evaluations of DPP-4 inhibitors is currently lacking.
Objectives
...
Alternative Titles
Full title
Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1683755781
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1683755781
Other Identifiers
ISSN
1170-7690
E-ISSN
1179-2027
DOI
10.1007/s40273-015-0266-y
